U.S. Markets close in 5 hrs 50 mins

Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017

GAITHERSBURG, Md., Feb. 20, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (NVAX) today announced it will report its fourth quarter and full year 2016 financial and operating results following the close of U.S. financial markets on Monday, February 27, 2017.

Conference call details are as follows:

Date:   Monday, February 27, 2017
Time:   4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:   (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:   61206704
Webcast:   www.novavax.com, "Investors"/ "Events"

Conference call and webcast replay:

Dates:   Starting at 7:30 p.m. ET, February 27, 2017, until midnight March 3, 2017
Dial-in number:   (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:   61206704
Webcast:   www.novavax.com, "Investors"/ "Events", until April 30, 2017

About Novavax

Novavax, Inc. (NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.


Investor Relations Novavax, Inc. Andrea N. Flynn, Ph.D. Associate Director, Investor Relations ir@novavax.com 240-268-2000

Westwicke Partners John Woolford john.woolford@westwicke.com 443-213-0506

Media Russo Partners, LLC David Schull Todd Davenport, Ph.D. david.schull@russopartnersllc.com 212-845-4271

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire